Cost-Effectiveness Analysis of Apixaban And Rivaroxaban For Treatment of Acute Venous Thromboembolism In China
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1244
https://www.valueinhealthjournal.com/article/S1098-3015(17)31578-4/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1195
First Page :
A618
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31578-4&doi=10.1016/j.jval.2017.08.1244